Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Hankerchiefon Oct 20, 2018 10:12am

130 Views

Post# 28840393

Options for getting Theralase/TLD 1433 to patients

This company actually has a 14% cure rate for solid tumors and charges $40,000 to $100,000 for treatment. If Theralase could just get a few patients treated for minimal cost and showed the good results we expect, then eyes would open IMO.

Interesting that they set up shop in the Caymans due to costs and administrative time length. People are dying that could be living while TLD-1433 sits in a bottle or can or bucket or whatever.

[url=https://https://gsabusiness.com/news/government/44688/][/url]

Bullboard Posts

Three micro-cap value stocks trading at peak pessimism